[HTML][HTML] Etiology and management of lack or loss of response to anti–tumor necrosis factor therapy in patients with inflammatory bowel disease
The management of patients with moderate to severe inflammatory bowel disease was
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
[引用][C] Etiology and management of lack or loss of response to anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
S Fine - Gastroenterol Hepatol, 2019 - cir.nii.ac.jp
Etiology and management of lack or loss of response to anti-tumor necrosis factor therapy in
patients with inflammatory bowel disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
patients with inflammatory bowel disease | CiNii Research CiNii 国立情報学研究所 学術情報 …
Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease.
S Fine, K Papamichael, AS Cheifetz - Gastroenterology & …, 2019 - europepmc.org
The management of patients with moderate to severe inflammatory bowel disease was
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
[PDF][PDF] Etiology and Management of Lack or Loss of Response to Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
S Fine, K Papamichael… - …, 2019 - gastroenterologyandhepatology.net
The management of patients with moderate to severe inflammatory bowel disease was
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
S Fine, K Papamichael… - Gastroenterology & …, 2019 - pubmed.ncbi.nlm.nih.gov
The management of patients with moderate to severe inflammatory bowel disease was
transformed with the arrival of anti-tumor necrosis factor (TNF) therapy. Nevertheless, a …
transformed with the arrival of anti-tumor necrosis factor (TNF) therapy. Nevertheless, a …
Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease.
S Fine, K Papamichael… - Gastroenterology & …, 2019 - search.ebscohost.com
The management of patients with moderate to severe inflammatory bowel disease was
transformed with the arrival of anti-tumor necrosis factor (TNF) therapy. Nevertheless, a …
transformed with the arrival of anti-tumor necrosis factor (TNF) therapy. Nevertheless, a …
[引用][C] Etiology and management of lack or loss of response to anti‐tumor necrosis factor therapy in patients with inflammatory bowel disease
S Fine - Gastroenterol. Hepatol., 2019 - cir.nii.ac.jp
Etiology and management of lack or loss of response to anti‐tumor necrosis factor therapy
in patients with inflammatory bowel disease | CiNii Research CiNii 国立情報学研究所 学術 …
in patients with inflammatory bowel disease | CiNii Research CiNii 国立情報学研究所 学術 …
[HTML][HTML] Etiology and Management of Lack or Loss of Response to Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
S Fine, K Papamichael… - …, 2019 - gastroenterologyandhepatology.net
The management of patients with moderate to severe inflammatory bowel disease was
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …
transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a …